AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glymset-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Razenta pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glymset-M1 Tablet SR

Diabetic patients using the extended-release Glymset-M1 tablet, a dual-action antidiabetic medication, manage their type 2 diabetes mellitus. This combined therapy regulates blood glucose effectively in adult patients. Always take this medication with food, consistently at the same time daily for optimal results. Dosage is determined and adjusted by your physician based on your blood glucose response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb loss. Remember, Glymset-M1 is one component of a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as guided by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them promptly. Maintain regular meals and always carry a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections; some individuals may experience weight gain. Glymset-M1 is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating women should consult their doctor before use. Regular blood glucose monitoring, along with blood cell count and liver function tests as advised by your doctor, are essential.

Uses of Glymset-M1 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glymset-M1 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glymset-M1 Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medicine with a meal.

Common Side effects of Glymset-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glymset-M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glymset-M1 Tablet SR. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Glymset-M1 Tablet SR works:

Glymset-M1 SR tablets contain glimepiride and metformin, two medications that manage blood sugar levels. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness in the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glymset-M1 Tablet SR and alcohol poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glymset-M1 Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glymset-M1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glymset-M1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glymset-M1 Tablet SR use. Physician consultation is necessary. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glymset-M1 Tablet SR cautiously, potentially requiring dose modification. Medical advice is essential. For those with mild to moderate liver disease, Glymset-M1 Tablet SR is typically initiated at a low dosage; however, it's contraindicated in patients with severe liver dysfunction.

What if you forget to take Glymset-M1 Tablet SR :

Should you forget a Glymset-M1 Tablet SR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glymset-M1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glymset-M1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glymset-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience these symptoms, discontinue Glymset-M1 Tablet SR and seek immediate medical attention.
Glymset-M1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glymset-M1 SR is not suitable for type 1 diabetes.
Glymset-M1 SR tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glymset-M1 Tablet SR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplementation with vitamin B12 is recommended by some researchers.
Glymset-M1 SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glymset-M1 Tablet SR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Glymset-M1 Tablet SR
52
MRP 63
17% off